Made by Revive harm reduction therapyis the second commercial naloxone product approved by the FDA this year.
Naloxone is a drug that helps Reduce deaths from opioid overdose And if given in a timely manner (usually within minutes of the first sign of an opioid overdose), it can prevent the effects of an overdose.
The company said it expects RiVive to be available. early 2024primarily to harm reduction groups and state governments, at a lower price than other opioid reversing nasal sprays.
The nonprofit is focused on supplying RiVive to the communities that need it most, and said it will manufacture at least 200,000 doses, representing 10% of its initial projected annual production volume. Available for free.
“We are grateful that the FDA has given RiVive approval.This will allow a wide range of non-prescription, low-cost nasal naloxone products to save lives that can be lost to opioid overdoses. We have been able to achieve what seemed almost impossible and other companies have not been able to: to provide a said in a statement:
Unlike other naloxone products, Harm Reduction Therapeutics said it will make RiVive available for free or at a low break-even cost, which the company has previously said. $18.
Narcan is the most popular naloxone product, and the FDA approved an over-the-counter version in March.
However, price can be a major barrier, as the 2-pack of the prescription version is expensive. $130 to $150, depending on the retailer. Even if he’s at a discounted price of around $50, he can still be a barrier.
